Occupational Therapists in Celina, OH Accepting Medicare

8 Occupational Therapists found. Showing 1 - 8

Mrs. Emily Rose Selhorst, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 441 E Market St, Celina, OH 45822 Phone: 419-586-6628

Kendra Janelle Koesters, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Myers Rd, Celina, OH 45822 Phone: 419-586-6645

Sarah Harner, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 441 E Market St, Celina, OH 45822 Phone: 419-586-6628

Mrs. Sandra Carolyn Bertke, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1915 Havemann Rd, Celina, OH 45822 Phone: 419-586-2100

Mindy Muhlenkamp, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 441 East Market Street, Celina, OH 45822 Phone: 419-586-6628

Michelle Winner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8363 Brockman Rd, Celina, OH 45822 Phone: 419-925-4760

Kylene Tobin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Myers Rd, Celina, OH 45822 Phone: 419-586-6645

James Lewis Moneer, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Myers Rd, Celina, OH 45822 Phone: 419-586-6645

News Archive

23andMe, Pfizer jointly launch Lupus Research Study

23andMe, Inc., the leading personal genetics company, today announced the launch of the Lupus Research Study in collaboration with Pfizer Inc. The companies aim to enroll 5,000 individuals with systemic lupus erythematosus, more commonly known as lupus, into the study to help better understand the genetics of lupus.

Anti-diabetic drug alogliptin meets primary endpoint in EXAMINE trial

Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according to results of the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial presented at the European Society of Cardiology Congress.

Recent findings on rare genetic disorder may help develop new treatment options

Fresh discoveries about a rare genetic disorder that affects mainly boys may inform the development of therapies to treat the condition.

FDG-PET parameter predicts locally advanced lung cancer survival

High post-treatment concentrations of a radioactive imaging marker are predictive of worse overall survival from inoperable, locally advanced non-small-cell lung cancer, prospective study findings suggest.

Study sheds light on e-cigarette behaviors among teenagers in the U.S.

E-cigarette use among teenagers is growing in the U.S., and Hawaii teens take up e-cigarette use at higher rates than their mainland counterparts, a new study by University of Hawaii Cancer Center researchers has found.

Read more Medical News

› Verified 8 days ago